Condition

Refractory Hodgkin Lymphoma clinical trials and research

• 6Clinical trials
• 4Countries

Newest Refractory Hodgkin Lymphoma clinical trials

All recruiting trials (6)

• ctDNA-guided therapy for relapsed or refractory Hodgkin lymphoma using pembrolizumab with GVD

  This study tests a pembrolizumab-based regimen plus chemotherapy in adults with relapsed or refractory classic Hodgkin lymphoma to see if ctDNA can guide treatment response and consolidation choices.

  Recruiting Phase 2 University of California, San Francisco · Davis, California and 5 other locations · NCT07021989

• Treatment for advanced tumors using HCB301

  This study is testing a new treatment called HCB301 to see if it can safely help adults with advanced tumors or relapsed Hodgkin lymphoma.

  Recruiting at 7 sites Phase 1 FBD Biologics Limited · Greenville, South Carolina and 6 other locations · NCT06487624

• Combination treatment of pembrolizumab and ATRA for relapsed Hodgkin and Non-Hodgkin lymphoma

  This study is testing if a combination of two treatments, pembrolizumab and ATRA, can help adults with relapsed Hodgkin and Non-Hodgkin lymphoma feel better and improve their health.

  Recruiting at 2 sites Phase 2 Indiana University · Indianapolis, Indiana and 1 other locations · NCT06484920

• New treatment approach for relapsed or refractory Hodgkin lymphoma

  This study is testing a new treatment for people with relapsed or hard-to-treat Hodgkin lymphoma to see if combining certain therapies can help them live longer and feel better.

  Recruiting Phase 2/3 Hospital Regional de Alta Especialidad del Bajio · León, Guanajuato · NCT05595447

• Combining Nivolumab and ASTX727 for B-Cell Lymphoma Treatment

  This study is testing a new combination of two treatments, nivolumab and ASTX727, to see if it can help people with relapsed or hard-to-treat B-cell lymphoma feel better and live longer.

  Recruiting at 8 sites Phase 1 National Cancer Institute (NCI) · Birmingham, Alabama and 8 other locations · NCT05272384

• Treatment for recurrent or refractory Hodgkin lymphoma using a combination of targeted therapy and chemotherapy

  This study is testing a new combination of targeted therapy and chemotherapy to see if it can help people with recurring or stubborn Hodgkin lymphoma before they undergo a stem cell transplant.

  Recruiting Phase 2 City of Hope Medical Center · Duarte, California · NCT04871607

Related topics

Quick answers

How many Refractory Hodgkin Lymphoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (5 trials), Mexico (1 trial), China (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →